Application interface and display control in an analyte monitoring environment

US10360368B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10360368-B2
Application numberUS-201414575950-A
CountryUS
Kind codeB2
Filing dateDec 18, 2014
Priority dateDec 27, 2013
Publication dateJul 23, 2019
Grant dateJul 23, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of monitoring an analyte level of a human with an in vivo analyte sensor and a mobile communication device, the method comprising: downloading and installing, by a user, a first application onto the mobile communication device; downloading and installing, by the user, a different second application onto the mobile communication device, wherein the first application is a sensor interface application and the second application is a user interface application; receiving data, at the mobile communication device, from the in vivo analyte sensor; processing the received data with the sensor interface application to generate data indicative of an analyte level of the human; determining, by the sensor interface application, whether the user interface application is authorized by reference to a registration database; granting, by the sensor interface application to the user interface application, if authorized, access to the data indicative of the analyte level of the human; communicating the data indicative of the analyte level of the human from the sensor interface application to the user interface application; causing, by the user interface application, display of the analyte level of the human on a display of the mobile communication device; and if an indication is received, at the sensor interface application, that access of the user interface application to the data indicative of the analyte level of the human is to be removed, then removing access of the user interface application to the data indicative of the analyte level of the human. 2. The method of claim 1 , wherein the user interface application is a first user interface application adapted to cause display of the analyte level of the human on the display of the mobile communication device, and the sensor interface application also communicates with a second user interface application adapted to cause display of the analyte level of the human on the display of the mobile communication device. 3. The method of claim 2 , further comprising the following steps performed by the sensor interface application: causing the capture of data from either the first user interface application or the second user interface application; and providing the captured data to the other of the first or second user interface applications. 4. The method of claim 1 , further comprising the following steps performed by the sensor interface application: determining that a critical event has occurred; and providing an indication to the user interface application that the critical event has occurred. 5. The method of claim 4 , further comprising: if a confirmation was not received from the user interface application that a notification of the critical event was provided to the user, then requesting that the user interface application provide the notification to the user. 6. The method of claim 5 , further comprising: after requesting that the user interface application provide the notification, if a confirmation was not received from the user interface application that the notification was provided, then disconnecting the user interface application from the sensor interface application. 7. The method of claim 5 , further comprising: after requesting that the user interface application provide the notification, if a confirmation was not received from the user interface application that the notification was provided, then logging the critical event and sending an error message to a trusted computer system over the internet. 8. The method of claim 4 , further comprising: if a confirmation was not received from the user interface application that a notification of the critical event was provided to the user, then providing the indication to user interface application that the critical event has occurred a second time. 9. The method of claim 8 , further comprising: after providing the indication to the user interface application a second time, if a confirmation was not received from the user interface application that the notification was provided, then disconnecting the user interface application from the sensor interface application. 10. The method of claim 8 , further comprising: after providing the indication to the user interface application a second time, if a confirmation was not received from the user interface application that the notification was provided, then logging the critical event and sending an error message to a trusted computer system over the internet. 11. The method of claim 4 , wherein the critical event is based on an analyte level sensed in the human or wherein the critical event is an error that has occurred in the in vivo analyte sensor or the sensor interface application. 12. A mobile communication device, comprising: a non-transitory memory on which a user downloadable sensor interface application and a user downloadable user interface application are stored; an RF transceiver adapted to receive data from an in vivo analyte sensor; and at least one processor communicatively coupled with the non-transitory memory and the RF transceiver, wherein the at least one processor is adapted to execute the user downloadable sensor interface application and adapted to: process the received data with the user downloadable sensor interface application to generate data indicative of an analyte level of the human; determine, with the user downloadable sensor interface application, whether the user downloadable user interface application is authorized by reference to a registration database; grant, with the user downloadable sensor interface application to the user downloadable user interface application, if authorized, access to the data indicative of the analyte level of the human; communicate the data indicative of the analyte level of the human from the user downloadable sensor interface application to the user downloadable user interface application, wherein the user downloadable sensor interface application and the user downloadable user interface application are both operating on the mobile communication device; and cause display of the analyte level of the human on a display of the mobile communication device with the user interface application; and if there is receipt of an indication, at the user downloadable sensor interface application, that access of the user downloadable user interface application to the data indicative of the analyte level of the human is to be removed, then remove access of the user downloadable user interface application to the data indicative of the analyte level of the human. 13. The mobile communication device of claim 12 , wherein the user downloadable user interface application is a first user interface application adapted to cause display of the analyte level of the human on the display of the mobile communication device, and the user downloadable sensor interface application is adapted to communicate with a second user interface application adapted to cause display of the analyte level of the human on the display of the mobile communication device. 14. The mobile communication device of claim 13 , wherein the at least one processor is further adapted to: cause the capture of data from either the first user interface application or the second user interface application; and provide the captured data to the other of the first or second user interface applications. 15. The mobile communication device of claim 12 , wherein the at least one processor is further adapted to: determine that a critical event has occurred; and provide an indication to the user downloadable user

Assignees

Inventors

Classifications

  • Communication to or from blood sampling device (transmitting measured data A61B5/0002) · CPC title

  • Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication · CPC title

  • specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks · CPC title

  • G06F21/44Primary

    Program or device authentication · CPC title

  • for local operation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10360368B2 cover?
Systems, devices, and methods are provided for the control of interfacing between applications that facilitate the monitoring of diabetes running on a mobile device, including the authentication of a third party user interface application by a sensor interface application. Control of the display of current analyte levels and critical events is also provided.
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification G06F21/44. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).